Identification and treatment of individuals with attentiondeficit/ hyperactivity disorder and substance use disorder: An expert consensus statement  

作　　者：Susan Young Cyrus Abbasian Zainab Al-Attar Polly Branney Bill Colley Samuele Cortese Sally Cubbin Quinton Deeley Gisli Hannes Gudjonsson Peter Hill Jack Hollingdale Steve Jenden Joe Johnson Deborah Judge Alexandra Lewis Peter Mason Raja Mukherjee David Nutt Jane Roberts Fiona Robinson Emma Woodhouse Kelly Cocallis 

机构地区：[1]Department of Psychology,Psychology Services Limited,Croydon CR97AE,United Kingdom [2]Department of Psychology,Reykjavik University,Reykjavik,Iceland [3]Psychiatry-UK Limited,Cornwall PL339ET,United Kingdom [4]ADHD and Autism,Oxford ADHD&Autism Centre,Headington OX37BX,United Kingdom [5]CLC Consultancy,Dunkeld PH80AY,United Kingdom [6]Center for Innovation in Mental Health,School of Psychology,Faculty of Environmental and Life Sciences,University of Southampton,Southampton SO171BJ,United Kingdom [7]Adult ADHD,Adult ADHD Clinic Ltd,Oxford OX37RP,United Kingdom [8]Forensic and Neurodevelopmental Science,Institute of Psychiatry,Psychology&Neuroscience,King's College London Institute of Psychiatry,London SE58AF,United Kingdom [9]Department of Psychology,Institute of Psychiatry,Psychology&Neuroscience,King's College London,London SE58AF,United Kingdom [10]Department of Psychiatry,University of London,London WC1E 7HU,United Kingdom [11]Department of Psychology,Compass Psychology Services Ltd,London BR19DX,United Kingdom [12]Birribi Ltd,Narberth SA677DU,United Kingdom [13]Halton and Knowsley Adult ADHD Team,Merseycare NHS Foundation Trust,Winwick WA29WA,United Kingdom [14]Department of Psychiatry,Fulbourn Hospital,Cambridge CB215EF,United Kingdom [15]Department of Psychiatry,Dr Peter Mason ADHD&Psychiatry Services Limited,Liverpool L19AR,United Kingdom [16]Adult Neurodevelopmental Service,Horizon House,Epsom KT174QJ,United Kingdom [17]Department of Psychiatry,Imperial College London,London WS120NN,United Kingdom [18]Service User Representative,Gloucestershire GL13NN,United Kingdom [19]Drug&Alcohol Services,Surrey&Borders Partnership Trust,Leatherhead KT227AD,United Kingdom [20]Forensic and Neurodevelopmental Sciences,Institute of Psychiatry,Psychology&Neuroscience,King's College London,London SE58AF,United Kingdom [21]Wansbeck General Hospital,Northumbria Healthcare NHS Foundation Trust,Ashington NE639JJ,United Kingdom

出　　处：《World Journal of Psychiatry》2023年第3期84-112,共29页世界精神病学杂志

摘　　要：Attention-deficit/hyperactivity disorder(ADHD)often co-occurs with substance use(SU)and/or substance use disorder(SUD).Individuals with concurrent ADHD and SU/SUD can have complex presentations that may complicate diagnosis and treatment.This can be further complicated by the context in which services are delivered.Also,when working with young people and adults with co-existing ADHD and SU/SUD,there is uncertainty among healthcare practitioners on how best to meet their needs.In February 2022,the United Kingdom ADHD Partnership hosted a meeting attended by multidisciplinary experts to address these issues.Following presentations providing attendees with an overview of the literature,group discussions were held synthesizing research evidence and clinical experience.Topics included:(1)A review of substances and reasons for use/misuse;(2)identification,assessment and treatment of illicit SU/SUD in young people and adults with ADHD presenting in community services;and(3)identification,assessment and treatment of ADHD in adults presenting in SU/SUD community and inpatient services.Discussions highlighted inter-service barriers and fragmentation of care.It was concluded that a multimodal and multi-agency approach is needed.The consensus group generated a table of practice recommendations providing guidance on:identification and assessment;pharmacological and psychological treatment;and multi-agency interventions.

关 键 词：Attention-deficit/hyperactivity disorder Substance use PHARMACOKINETICS Assessment Treatment COMORBIDITY 

分 类 号：R749.94[医药卫生—神经病学与精神病学]